- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Generic drug cost change for Canada 2016-2018
Premium statistics
Industry-specific and extensively researched technical data (partially from exclusive partnerships).
A paid subscription is required for full access.
Generic drug cost change for Canada 2016-2018
Generic drug cost growth for Canada from 2016 to 2018
by Statista Research Department,
last edited
Jan 1, 2016
This statistic illustrates a forecast for generic drug pricing change in Canada from 2016 to 2018. For 2018, generic drug costs are projected to increase some 6.6 percent.
Generic drug cost growth for Canada from 2016 to 2018
| Pricing ratio | |
|---|---|
| - | - |
| - | - |
| - | - |
| Pricing ratio | |
|---|---|
| - | - |
| - | - |
| - | - |
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1.5m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
Exclusive content
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1.5m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Chart type
Datalabels
Share on Social Media
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
by Statista Research Department,
last edited
Jan 1, 2016
This statistic illustrates a forecast for generic drug pricing change in Canada from 2016 to 2018. For 2018, generic drug costs are projected to increase some 6.6 percent.
- Show sources information
- As a Premium user you get access to the detailed source references and background information about this statistic.
- Show publisher information
- Release date
- January 2016
- Region
- Canada
- Survey time period
- as of 2016
- Supplementary notes
- All values are forecasts.
Source
- Show sources information
- As a Premium user you get access to the detailed source references and background information about this statistic.
- Show publisher information
- Release date
- January 2016
More information
- Region
- Canada
- Survey time period
- as of 2016
- Supplementary notes
- All values are forecasts.
Other statistics on the topic
+Pharmaceutical Products & Market
Research and development in European pharmaceutical industry by country 2017
+Pharmaceutical Products & Market
VAT rate on prescription-only drugs in Europe 2018
+Pharmaceutical Products & Market
Leading 18 European pharmaceutical companies by retail sales 2015
Pharmaceutical Products & Market
Market share of generics in European countries 2017
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Statista is a great source of knowledge, and pretty helpful to manage the daily work.Christof Baron
CEO, MindShare Germany
Statistics on "Pharmaceutical trends in Europe"
- Overview
The most important statistics
- Turnover of leading pharmaceutical markets in Europe in 2017 (in million euros)Turnover of leading European pharmaceutical markets 2017
- Turnover of pharmaceutical markets in Central and Eastern Europe in 2017 (in million euros)Turnover of pharmaceutical markets in Central and Eastern Europe 2017
- Share of breakdown of pharmaceutical price structure in Europe in 2016*Pharmaceutical price structure breakdown in Europe 2016
- Value Added Tax (VAT) rate on over-the-counter (OTC) drugs in Europe in 2018, by country*VAT rate on over-the-counter drugs in Europe 2018, by country
- Value Added Tax (VAT) rate on prescription-only drugs in Europe in 2018, by countryVAT rate on prescription-only drugs in Europe 2018
- Share of GDP expenditure on research and development in the EU-28 countries from 2000 to 2017*European Union: share of GDP expenditure on research and development 2000-2017
- Pharmaceutical research and development spending in selected European countries in 2017 (in million euros)Research and development in European pharmaceutical industry by country 2017
- Annual growth of pharmaceutical R&D spending in Europe and the U.S. between 2004 and 2018Yearly growth rate of R&D spending in pharmaceutical industry 2004-2018
- European Pharmaceutical companies
The most important statistics
- Leading 18 European pharmaceutical companies by retail sales in 2015 (in billion U.S. dollars)Leading 18 European pharmaceutical companies by retail sales 2015
- Leading pharmaceutical and biotechnology companies in Europe in 2015, based on market value (in million U.S. dollars)Leading European pharmaceutical & biotechnology companies ranked by market value 2015
- Leading European pharmaceutical companies by spending on research and development in 2015 (in million U.S. dollars)Leading European pharmaceutical companies by R&D spending 2015
- Leading European pharmaceutical companies by investment in research and development in 2014 (in million U.S. dollars)Leading European pharmaceutical companies by R&D investment 2014
- Pharmaceutical production value of EFPIA members from 1990 to 2018 (in million euros)Members of EFPIA's pharmaceutical production value 1990-2018
- Pharmaceutical research and development spending of EFPIA members from 1990 to 2018 (in million euros)Members of EFPIA's pharmaceutical R&D spending 1990-2018
- Self-medication market
The most important statistics
- Sales in the self-medication market in selected European countries in 2017 (in million euro)Self-medication market sales in Europe in 2017, by country
- Sales of analgesics in the self-medication market in Europe in 2017, by country (in million euro)Self-medication market sales of analgesics in Europe in 2017, by country
- Sales of cough and cold products in the self-medication market in Europe in 2017, by country (in million euro)Cough and cold self-medication market sales in Europe in 2017
- Sales of digestives and intestinal remedies in the self-medication product market in Europe in 2017, by country (in million euro)Digestives and intestinal remedies self-medication market sales in Europe 2017
- Sales of self-medication skin treatment products in Europe in 2017, by country (in million euros)Self-medication skin treatment product sales in Europe 2017, by country
- Sales of vitamin and mineral products in the self medication market in Europe in 2017, by country (in million euro)Self-medication: sales of vitamins and minerals in Europe 2017
- Market value of self-medication drugs in Italy from 2014 to 2017 (in million euros)Italy: market value of self-medication drugs 2014-2017
- Sales revenue of self-care medicines in the Netherlands in 2017, by purchase channel (in million euros)Sales revenue of self-care medicines in the Netherlands 2017, by purchase channel
- Employment
The most important statistics
- Pharmaceutical employment in selected European countries in 2017Employment in European pharmaceutical industry by country 2017
- Total pharmaceutical employment in EFPIA countries from 1990 to 2018Employment in EFPIA pharmaceutical industry 1990-2018
- Employment in pharmaceutical products and preparations manufacturing in the United Kingdom from 2008 to 2017 (in 1,000s)Pharmaceutical manufacturing employment in the United Kingdom 2008-2017
- Number of employees in biotechnology companies, split by private or public sector in Switzerland from 2012 to 2017Switzerland: number of employees in biotech companies 2012-2017
- Number of employees in the pharmaceutical industry in Germany from 2010 to 2016Pharmaceutical industry: number of employees in Germany 2010-2016
- Number of employees in the pharmaceutical industry in Belgium from 2014 to 2017Number of employees in the pharmaceutical industry in Belgium 2014-2017
- Number of employees of pharmaceutical companies in France in 2014, by region of residenceNumber of employees of pharmaceutical companies by region France 2014
- Number of employees in the pharmaceutical industry in Italy between 2000 and 2018Number of employees in the pharmaceutical industry in Italy 2000-2018
- Clinical Trials
The most important statistics
- Distribution of European clinical and phase III pipeline in 2013, by indicationDistribution of European clinical and phase III pipeline 2013 by indication
- Number of clinical trials submitted to the European Medicines Agency from European countries from 2005 to 2011Pivotal trials submitted to the European Medicines Agency from Europe 2005-2011
- Number of patients per clinical trial in selected European countries from 2005 to 2011Patients in clinical trials in selected European countries 2005-2011
- Number of applications to conduct a clinical trial submitted to BfArM and PEI* in Germany from 2009 to 2017Clinical trial conduct applications in Germany 2009-2017
- Number of clinical trials authorized by the competent authority in Italy from 2003 to 2017Italy: number of clinical trials authorized in Italy 2003-2017
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Generic drug savings forecast for Canada 2015-2017
- Share of private drug plan drug costs in Canada by therapeutic class 2012
- Generic share of dispensed prescriptions by formulation U.S. 2012 vs. 2017
- Spending on dispensed total vs. generic prescriptions in the U.S. 2017
- U.S. total vs. generic dispensed prescription numbers 2017, by formulation
- Generics prescriptions dispensed in the U.S. 2010-2016
- Top generic entry drug savings in Canada by public drug plan 2012/2013
- Generic drug savings by top drug in Canada's public drug plans 2012/2013
- Dispensing costs for tablets of generic drugs by public drug plan 2016/17
- Number of public drug plan prescriptions in Canada 2016/2017
- Average day supply per prescription in Canada by public drug plan 2016/2017
- Generic drugs average unit cost index in Canada by public drug plan 2013/2014
- growth in 90 day prescriptions U.S. 2013-2020
- Share of 90 day prescriptions that are mail or retail dispensed 2013-2020
- Percentage chronic therapy dispensed as 90 day prescriptions 2013-2020
- Italy: private expenditure for socio-medical care 2011-2017
- Generics prescribed at the hospital and delivered in the city in France 2014
- Intention to buy private health insurance in Australia 2018
- Changes in payments for family's private health insurance in the United States 2003-2012
- Canadians enrolled in private health insurance 2017, by province
Studies
- Antibiotic use in the United Kingdom (UK)
- Compass Rx - Annual Public Drug Plan Expenditure Report 2012/13
- The Oregon Medical Marijuana Program (April 2019)
- Prescription Cost Analysis, England 2018
- Compass Rx - Annual Public Drug Plan Expenditure Report 2013/14
- Compass Rx - Annual Public Drug Plan Expenditure Report 2015/16
- The Oregon Medical Marijuana Program (April 2018)
- Medical Marijuana Patient Survey Results January 2016
- Weed and the American Family
- Weed and the American Family: Part 2
- Prescription drug access and affordability an issue for nearly a quarter of all Canadian h...
- Prescription Cost Analysis, England 2014
- Prescribing by dentists, England 2013
- The Oregon Medical Marijuana Program (April 2017)
- The Oregon Medical Marijuana Program (July 2016)
Statistics on "Pharmaceutical trends in Europe"
- Turnover of leading pharmaceutical markets in Europe in 2017 (in million euros)
- Turnover of pharmaceutical markets in Central and Eastern Europe in 2017 (in million euros)
- Share of breakdown of pharmaceutical price structure in Europe in 2016*
- Value Added Tax (VAT) rate on over-the-counter (OTC) drugs in Europe in 2018, by country*
- Value Added Tax (VAT) rate on prescription-only drugs in Europe in 2018, by country
- Share of GDP expenditure on research and development in the EU-28 countries from 2000 to 2017*
- Pharmaceutical research and development spending in selected European countries in 2017 (in million euros)
- Annual growth of pharmaceutical R&D spending in Europe and the U.S. between 2004 and 2018
- Market share of generics in selected European countries as of 2017
- Leading 18 European pharmaceutical companies by retail sales in 2015 (in billion U.S. dollars)
- Leading pharmaceutical and biotechnology companies in Europe in 2015, based on market value (in million U.S. dollars)
- Leading European pharmaceutical companies by spending on research and development in 2015 (in million U.S. dollars)
- Leading European pharmaceutical companies by investment in research and development in 2014 (in million U.S. dollars)
- Pharmaceutical production value of EFPIA members from 1990 to 2018 (in million euros)
- Pharmaceutical research and development spending of EFPIA members from 1990 to 2018 (in million euros)
- Sales in the self-medication market in selected European countries in 2017 (in million euro)
- Sales of analgesics in the self-medication market in Europe in 2017, by country (in million euro)
- Sales of cough and cold products in the self-medication market in Europe in 2017, by country (in million euro)
- Sales of digestives and intestinal remedies in the self-medication product market in Europe in 2017, by country (in million euro)
- Sales of self-medication skin treatment products in Europe in 2017, by country (in million euros)
- Sales of vitamin and mineral products in the self medication market in Europe in 2017, by country (in million euro)
- Market value of self-medication drugs in Italy from 2014 to 2017 (in million euros)
- Sales revenue of self-care medicines in the Netherlands in 2017, by purchase channel (in million euros)
- Sales revenue of self-care medicines in supermarkets in the Netherlands in 2017, by product segment (in million euros)
- Pharmaceutical employment in selected European countries in 2017
- Total pharmaceutical employment in EFPIA countries from 1990 to 2018
- Employment in pharmaceutical products and preparations manufacturing in the United Kingdom from 2008 to 2017 (in 1,000s)
- Number of employees in biotechnology companies, split by private or public sector in Switzerland from 2012 to 2017
- Number of employees in the pharmaceutical industry in Germany from 2010 to 2016
- Number of employees in the pharmaceutical industry in Belgium from 2014 to 2017
- Number of employees of pharmaceutical companies in France in 2014, by region of residence
- Number of employees in the pharmaceutical industry in Italy between 2000 and 2018
- Distribution of European clinical and phase III pipeline in 2013, by indication
- Number of clinical trials submitted to the European Medicines Agency from European countries from 2005 to 2011
- Number of patients per clinical trial in selected European countries from 2005 to 2011
- Number of applications to conduct a clinical trial submitted to BfArM and PEI* in Germany from 2009 to 2017
- Number of clinical trials authorized by the competent authority in Italy from 2003 to 2017
- Forecast of generic drug savings in Canada from 2015 to 2017 (in million Canadian dollars)
- Share of Canada's private drug plan drug costs in 2012, by therapeutic class
- Percentage of U.S. dispensed prescriptions that were generics in 2012 and 2017, by formulation
- Spending on dispensed total vs. generics prescriptions in the U.S. in 2017, by formulation (in billion U.S. dollars)
- Number of dispensed total vs. generics prescriptions in the U.S. in 2017, by formulation (in millions)
- Total number of generic drug prescriptions dispensed in the U.S. from 2010 to 2016 (in millions)*
- Savings for top 5 generic entry drugs in select Canadian drug plans in 2012/2013 (in 1,000 Canadian dollars)
- Total generic drug savings in Canadian public drug plans in 2012/2013, by top drug (in million Canadian dollars)*
- Dispensing costs for tablets of common generic drugs by public drug plan in Canada comparing 2012/2013 and 2016/2017 (in 1,000 Canadian dollars)*
- Number of prescriptions in select Canadian public drug plans in 2016/2017 (in millions)
- Average day supply per prescription in select Canadian public drug plans in 2016/2017
- Average unit cost index for generic drugs in Canada by public drug plan from 2009/2010 to 2013/2014
- Growth in number of 90-day adjusted prescriptions dispensed in the U.S. from 2013 to 2020*
- Percentage of 90-day adjusted prescriptions dispensed by mail or retail from 2013 to 2020
- Percentage of prescriptions for chronic illness that were dispensed as 90-day prescriptions from 2013 to 2020*
- Private expenditure for socio-medical care in Italy from 2011 to 2017 (in million euros)
- Generic substitution rate of drugs prescribed by the hospital and delivered in the city in France in 2014, according to pathology*
- Distribution of intended buyers of private health insurance in Australia in 2018, by age group
- Over the past year, has the amount you paid for your family's private health insurance changed? (2003-2012)*
- Number of Canadians that are enrolled in private health insurance in 2017, by province
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Save statistic in .XLS format
You can only download this statistic as a Premium user.
Save statistic in .PNG format
You can only download this statistic as a Premium user.
Save statistic in .PDF format
You can only download this statistic as a Premium user.
Show source references
As a Premium user you get access to the detailed source references and background information about this statistic.
Show details about this statistic
As a Premium user you get access to background information and details about the release of this statistic.
Bookmark statistics
As soon as this statistic is updated, you will immediately be notified via e-mail.
Change statistics options
You need at least a Premium Account to use this feature.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.